Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Vita-Salute San Raffaele University at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Vita-Salute San Raffaele University brings 3 presentations to ASH 2026 in New Orleans. Its research spans CAR-T cell engineering, CLL and clonal evolution. Work covers a C3d-directed CAR-T platform, MRD results with dose-modified therapy and single-cell lineage tracing.

OrganizationASH 2026 Attendance
Universities & research institutes
Private medical and life-sciences university in Milan linked to the San Raffaele hospital and research institute.
Symposium
Fri Dec 11
3:00pm–6:00pm
FAST Track to Enhanced CLL Outcomes: Finite Therapy Advances With BTK Inhibitors as New STandards for Frontline Treatment
Time-limited frontline chronic lymphocytic leukemia treatment pairing Bruton tyrosine kinase and Bcl-2 inhibitors, tailored to patient goals and risk.
Symposium hosted by PeerView Institute for Medical Education
Lymphoma · New drugs
Session
Fri Dec 11
3:00pm–6:00pm
Scientific Workshop on Clonal Evolution in Chronic Lymphocytic Leukemia: Mechanisms of Resistance, Disease Progression and Measurable Residual Disease-Based Monitoring
How chronic lymphocytic leukemia evolves, resists targeted drugs and progresses, and how residual-disease testing can track those changes.
Lymphoma

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Vita-Salute San Raffaele University

Tell us what you sell and we’ll find the people at Vita-Salute San Raffaele University most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction